Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies.

J Clin Med · 2020 · PMC7291235 · PMID 32443612

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

did not reach statistical significancep = 0.052so close (0.05 < p ≤ 0.1)

CVD death differences between AFB and RBZ in our study did not reach statistical significance; nevertheless, in VIEW 1,2, considering it separately, it was near this level (pair-wise Fisher’s exact test provided p = 0.052).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.